Rechercher
5 études correspondent à ces filtres. Affichage de 1 à 5 sur 5 études
| Numéro d'enregistrement | Étude | Statut | Phase | Recrutement | Sites / pays | Année de début | Dernière mise à jour | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT01574053 | Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into… ✓ Contact✗ Revendiqué Centre le plus proche : Wichita, Kansas, United States — à 43 km · 183 centres au total · contact indiqué | En recrutementNon vérifié depuis 1 févr. 2024 | 35 000objectif | 183 / 20 | 2012 | 28 févr. 2024 | ||
| NCT07609108 | Pridopidine Phase 3 Study in Huntington's Disease The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over… ✓ Contact✗ Revendiqué Centre le plus proche : Wichita, Kansas, United States — à 43 km · 66 centres au total · contact indiqué | En recrutement | Phase 3 | 400objectif | 66 / 12 | 2026 | 17 sept. 2026 | |
| NCT05491525 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC ✓ Contact✗ Revendiqué Centre le plus proche : Wichita, Kansas, United States — à 43 km · 38 centres au total · contact indiqué | En recrutement | Phase 2 / Phase 3 | 71objectif | 38 / 16 | 2022 | 15 juin 2026 | |
| NCT07190300 | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). ✓ Contact✗ Revendiqué Centre le plus proche : Wichita, Kansas, United States — à 43 km · 31 centres au total · contact indiqué | En recrutement | Phase 1 / Phase 2 | 181objectif | 31 / 14 | 2026 | 23 juin 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contact✗ Revendiqué Centre le plus proche : Wichita, Kansas, United States — à 43 km · 279 centres au total · contact indiqué | En recrutement | 75 000objectif | 279 / 6 | 2015 | 25 août 2026 |